Cosmos Health (COSM) EBIT Margin (2014 - 2026)
Cosmos Health's (COSM) quarterly EBIT Margin came in at 12.18% in Q1 2026, down 611.0% YoY from 2.38% in Q1 2025, and down 146.86% on a QoQ basis from 26.0% in Q4 2025.
Cosmos Health (COSM) EBIT Margin (2014 - 2026) Analysis & Trends
Cosmos Health (COSM) has 12 years of EBIT Margin data on file, last reported at 12.18% in Q1 2026.
- Quarterly EBIT Margin fell 611.0% year-over-year to 12.18% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 305.22% (down 27806.0% YoY) and the FY2025 annual result came in at 982.56%, down 95400.0% from the prior year.
- EBIT Margin retreated to 12.18% in Q1 2026, from 26.0% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 26.0% in Q4 2025 to a low of 85.77% in Q4 2023.
- A 5-year average of 20.42% and a median of 17.94% in 2025 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2022 — EBIT Margin slumped 5740 bps — and 2025, when it jumped 8904 bps.
- Tracing COSM's EBIT Margin over 5 years: stood at 60.56% in 2022, then tumbled by 42 bps to 85.77% in 2023, then grew by 27 bps to 63.04% in 2024, then jumped by 141 bps to 26.0% in 2025, then slumped by 147 bps to 12.18% in 2026.
- The last three EBIT Margin figures came in at 12.18% (Q1 2026), 26.0% (Q4 2025), and 10.63% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 100.02 Bn | 94.85 Bn | 3.69 Bn | 1.25% |
| 2 | Cencora | 60.88 Bn | 58.06 Bn | 3.61 Bn | 1.32% |
| 3 | Cardinal Health | 54.14 Bn | 49.29 Bn | 2.56 Bn | 1.14% |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | 4.95% |
| 5 | Akso Health | 737.16 Mn | 736.96 Mn | - | - |
| 6 | Edap Tms | 159.12 Mn | 137.58 Mn | 7.34 Mn | -60.84% |
| 7 | Accendra Health | 100.85 Mn | 93.20 Mn | 263.41 Mn | -5.73% |
| 8 | 111 | 32.10 Mn | -26.65 Mn | 18.18 Mn | -0.84% |
| 9 | Cosmos Health | 12.73 Mn | 10.29 Mn | 1.51 Mn | -15.41% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | -6.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.18% |
| Dec 31, 2025 | 26.00% |
| Sep 30, 2025 | -10.63% |
| Jun 30, 2025 | -17.94% |
| Mar 31, 2025 | -6.08% |
| Dec 31, 2024 | -63.04% |
| Sep 30, 2024 | -18.05% |
| Jun 30, 2024 | -18.95% |
| Mar 31, 2024 | -12.59% |
| Dec 31, 2023 | -85.77% |
| Sep 30, 2023 | -23.53% |
| Jun 30, 2023 | -20.84% |
| Mar 31, 2023 | -21.47% |
| Dec 31, 2022 | -60.56% |
| Sep 30, 2022 | -2.86% |
| Jun 30, 2022 | -0.56% |
| Mar 31, 2022 | 1.85% |
| Dec 31, 2021 | -3.16% |
| Sep 30, 2021 | -6.73% |
| Jun 30, 2021 | -9.27% |